This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Sinntaxis Ab. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: **Karsten Ruscher: Innovator in Brain Damage Treatment**
Introduction
Karsten Ruscher is an innovative inventor based in Lund, Sweden, recognized for his significant contributions to the field of neuroscience. With a focus on developing treatments for mature brain damage, Ruscher has dedicated his research efforts toward addressing challenging medical conditions.
Latest Patents
One of Ruscher's notable patents is titled "Negative allosteric modulators of MGLUR5 for use in the treatment of mature brain damages." This patent discloses the utilization of negative allosteric modulators (NAMs) of the metabotropic glutamate receptor 5 (mGluR5) to treat mature brain damage, including injuries resulting from strokes. This groundbreaking approach offers a potential pathway to enhance recovery and improve outcomes for individuals suffering from such conditions.
Career Highlights
Karsten Ruscher is currently employed at Sinntaxis AB, where he employs his expertise to advance the understanding and treatment of neurological disorders. His single patent reflects his commitment to innovation in the medical field, demonstrating both his technical proficiency and his dedication to improving patient care through scientific discovery.
Collaborations
In his pursuit of innovative solutions, Ruscher collaborates with esteemed colleagues, including Tadeusz Wieloch and Carin Sjölund. Together, they form a team that combines their diverse skills and knowledge to further enhance their research and development efforts in the area of brain health.
Conclusion
With his pioneering work on allosteric modulators for treating mature brain damage, Karsten Ruscher exemplifies the essence of innovation in the medical field. His contributions not only signify progress in therapeutic approaches but also inspire further advancements in neurology and patient treatment approaches. As researchers like Ruscher continue to explore new avenues, the potential for improved recovery for affected individuals grows significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile